[go: up one dir, main page]

BG34336A3 - Метод за получаване на производни на фталазин -4- ил-оцетна киселина - Google Patents

Метод за получаване на производни на фталазин -4- ил-оцетна киселина

Info

Publication number
BG34336A3
BG34336A3 BG041857A BG4185778A BG34336A3 BG 34336 A3 BG34336 A3 BG 34336A3 BG 041857 A BG041857 A BG 041857A BG 4185778 A BG4185778 A BG 4185778A BG 34336 A3 BG34336 A3 BG 34336A3
Authority
BG
Bulgaria
Prior art keywords
acetic acid
acid derivatives
phthalazine
obtaining
phthalazin
Prior art date
Application number
BG041857A
Other languages
Bulgarian (bg)
English (en)
Inventor
David Brittain
Robin Wood
Original Assignee
Imperial Chemical Industries Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Plc filed Critical Imperial Chemical Industries Plc
Publication of BG34336A3 publication Critical patent/BG34336A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG041857A 1977-12-29 1978-12-26 Метод за получаване на производни на фталазин -4- ил-оцетна киселина BG34336A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5414277 1977-12-29

Publications (1)

Publication Number Publication Date
BG34336A3 true BG34336A3 (bg) 1983-08-15

Family

ID=10470067

Family Applications (1)

Application Number Title Priority Date Filing Date
BG041857A BG34336A3 (bg) 1977-12-29 1978-12-26 Метод за получаване на производни на фталазин -4- ил-оцетна киселина

Country Status (31)

Country Link
US (2) US4251528A (hu)
EP (1) EP0002895B1 (hu)
JP (2) JPS5495582A (hu)
AT (1) AT365581B (hu)
AU (1) AU516264B2 (hu)
BG (1) BG34336A3 (hu)
CA (1) CA1107732A (hu)
CS (1) CS241015B2 (hu)
CY (1) CY1219A (hu)
DD (1) DD141021A5 (hu)
DE (1) DE2861170D1 (hu)
DK (1) DK151253C (hu)
ES (1) ES476496A1 (hu)
FI (1) FI64357C (hu)
GR (1) GR65303B (hu)
HK (1) HK22484A (hu)
HU (1) HU182585B (hu)
IE (1) IE47592B1 (hu)
IL (1) IL56099A0 (hu)
IN (1) IN150196B (hu)
IT (1) IT1110885B (hu)
MY (1) MY8500359A (hu)
NO (1) NO154346C (hu)
NZ (1) NZ189034A (hu)
PH (1) PH15435A (hu)
PL (1) PL118443B1 (hu)
PT (1) PT68956A (hu)
SG (1) SG68683G (hu)
SU (3) SU1087075A3 (hu)
YU (3) YU41607B (hu)
ZW (1) ZW24978A1 (hu)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
CA1143733A (en) * 1979-07-31 1983-03-29 Masao Yoshida Producing 7-alkoxycarbonyl-6,8-dimethyl-4- hydroxymethyl-1-phthalazone and intermediates
US4762839A (en) * 1985-06-06 1988-08-09 Tanabe Seiyaku Co., Ltd. Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications
ES2032749T3 (es) * 1985-11-07 1993-03-01 Pfizer Inc. Acidos oxoftalazinil-aceticos heterociclicos.
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
WO1993013092A1 (en) * 1986-11-24 1993-07-08 Reinhard Sarges Imidazolidinedione derivatives
GB8704569D0 (en) * 1987-02-26 1987-04-01 Ici America Inc Therapeutic agent
US4868301A (en) * 1987-06-09 1989-09-19 Pfizer Inc. Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
EP0315249A1 (en) * 1987-11-02 1989-05-10 Merck & Co. Inc. Phthalazineacetic acid composition and tablet
DK607188A (da) * 1987-11-02 1989-06-22 Merck & Co Inc Tablet indeholdende en phthalazineddikesyreforbindelse
US4880928A (en) * 1987-12-21 1989-11-14 Merck & Co., Inc. Process for the preparation of 3-((4-bromo-2-fluorophenyl)methyl)-3,4-dihydro-4-oxo-1-phthalazine-acetic acid
US4904782A (en) * 1988-02-29 1990-02-27 Pfizer Inc. Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
US4940791A (en) * 1988-02-29 1990-07-10 Pfizer Inc. Process for the production of phthalazineacetic acid ester derivatives and a novel hydrazine containing intermediate
US4996204A (en) * 1989-05-11 1991-02-26 Pfizer Inc. Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
EP0397930A1 (en) * 1989-05-18 1990-11-22 Merck & Co. Inc. Process for the preparation of 3-[(4-bromo-2-fluorophenyl) methyl]-3,4-dihydro-4-oxo-1-phthalazineacetic acid
FR2647676A1 (fr) * 1989-06-05 1990-12-07 Union Pharma Scient Appl Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase
FI922308L (fi) * 1989-12-15 1992-05-21 Pfizer Substituerade oxoftalazinylaettiks- syror och deras analoger.
US5037831A (en) * 1990-05-21 1991-08-06 American Home Products Corporation Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors
FR2682108B1 (fr) * 1991-10-07 1994-01-07 Lipha Acide 3,4-dihydro-4-oxo-3(prop-2-enyl)-1-phtalazineacetiques et derives, leurs preparations et medicaments les contenant.
EP0662962A1 (en) * 1992-09-28 1995-07-19 Pfizer Inc. Substituted pyrimidines for control of diabetic complications
CA2147504A1 (en) * 1992-11-02 1994-05-11 Prasun K. Chakravarty Substituted phthalazinones as neurotensin antagonists
CH683965A5 (it) * 1993-02-19 1994-06-30 Limad Marketing Exp & Imp Composti della classe dei ftalidrazidici come sostanza attiva in agenti antinfiammatori ed antitossici.
JPH09506068A (ja) * 1993-07-26 1997-06-17 藤沢薬品工業株式会社 悪液質治療のためのオキソフタラジン類
AU6473898A (en) * 1997-03-21 1998-10-20 Regents Of The University Of California, The Methods for modulating neurotrophic factor-associated activity using aldose reductase inhibitors
US6696407B1 (en) 1997-03-21 2004-02-24 The Regents Of The University Of California Huntington's disease treatment comprising administering aldose reductase inhibitors to increase striatal CNTF
CA2283564C (en) * 1997-04-15 2007-07-10 Csir Pharmaceutical compositions having appetite suppressant activity
AP2000001929A0 (en) * 1998-03-31 2000-09-30 Inst For Pharm Discovery Inc Substituted indolealkanoic acids.
TNSN99224A1 (fr) * 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
GB2355657B (en) * 1999-10-27 2004-07-28 Phytopharm Plc Inhibitors Of Gastric Acid Secretion
DE19963607B4 (de) * 1999-12-23 2005-12-15 Schering Ag Verfahren zur Herstellung von 4-(Heteroaryl-methyl) halogen-1(2H)-phthalazinonen
GB2363985B (en) * 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
EE200300249A (et) * 2000-11-30 2003-10-15 Pfizer Products Inc. GABA agonistide ja aldoosreduktaasi inhibiitoritekombinatsioon
ES2240657T3 (es) 2001-02-28 2005-10-16 Pfizer Products Inc. Compuestos de sulfonilpiridazinona utiles como inhibidores de aldosa reductasa.
EA006023B1 (ru) * 2001-03-30 2005-08-25 Пфайзер Продактс Инк. Пиридазиноновые ингибиторы альдозоредуктазы
IL157935A0 (en) * 2001-04-30 2004-03-28 Pfizer Prod Inc Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
AU761191B2 (en) 2001-05-24 2003-05-29 Pfizer Products Inc. Therapies for tissue damage resulting from ischemia
WO2003092696A1 (en) * 2002-04-30 2003-11-13 Novartis Ag Method for decreasing capillary permeability in the retina
CA2493755A1 (en) * 2002-07-26 2004-02-05 The Institutes For Pharmaceutical Discovery, Llc Substituted indolealkanoic acids derivative and formulations containing same for use in treatment of diabetic complications
US7572910B2 (en) * 2003-02-20 2009-08-11 Pfizer, Inc. Pyridazinone aldose reductase inhibitors
US20110092566A1 (en) * 2004-11-19 2011-04-21 Srivastava Satish K Treatment of cancer with aldose reductase inhibitors
JP4838582B2 (ja) * 2004-12-27 2011-12-14 岐阜プラスチック工業株式会社 台車用本体
EP2368560A1 (en) 2007-03-12 2011-09-28 Zadec ApS An anti-diabetic extract of rooibos
WO2008118844A1 (en) 2007-03-23 2008-10-02 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibitors
US20090270490A1 (en) * 2008-04-24 2009-10-29 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibition
AU2011348074B2 (en) 2010-12-23 2016-04-28 The Board Of Regents Of The University Of Texas System Methods for treating COPD
EP2931280B1 (en) * 2012-12-14 2018-02-14 Phusis Therapeutics Inc. Methods and compositions for inhibiting cnksr1
US10227356B2 (en) 2015-04-20 2019-03-12 Phusis Therapeutics, Inc. Compounds, compositions and methods for inhibiting CNKSR1
WO2019165195A1 (en) 2018-02-22 2019-08-29 Srivastava Satish Combination therapy for the treatment of cancer
WO2020071386A1 (ja) * 2018-10-04 2020-04-09 日東電工株式会社 耐熱離型シート及び熱圧着方法
JP6751974B1 (ja) * 2019-10-16 2020-09-09 株式会社コバヤシ 離型フィルム及び離型フィルムの製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3833579A (en) * 1935-11-11 1974-09-03 Inoue Michiro 4-carbamoyl phthalazones
JPS5116430B2 (hu) * 1971-08-05 1976-05-24
GB1398549A (en) * 1972-11-06 1975-06-25 Boots Co Ltd Phthalazine derivatives and their use in pharmaceutical compo sitions
AR205004A1 (es) * 1973-10-30 1976-03-31 Ishikawa M Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona
DE2451117A1 (de) * 1973-10-31 1975-05-22 Boots Co Ltd Therapeutisch wirksame verbindungen
GB1502312A (en) 1975-03-20 1978-03-01 Ici Ltd Quinolone derivatives
IE43079B1 (en) * 1975-03-20 1980-12-17 Ici Ltd Quinolone derivatives
JPS5214788A (en) * 1975-07-21 1977-02-03 Fuji Photo Film Co Ltd Process for preparing phthalazinone and its derivatives
NL7702763A (nl) * 1976-03-18 1977-09-20 Takio Shimamoto En Masayuki Is Werkwijze voor de bereiding van thromboxaan- -antagonisten en van preparaten die deze stof- fen bevatten.
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4293553A (en) * 1978-08-11 1981-10-06 Masayuki Ishikawa 1-Phthalazone derivatives, and use thereof

Also Published As

Publication number Publication date
ATA937678A (de) 1981-06-15
MY8500359A (en) 1985-12-31
IT7852480A0 (it) 1978-12-28
ES476496A1 (es) 1979-04-16
IN150196B (hu) 1982-08-14
GR65303B (en) 1980-08-01
HK22484A (en) 1984-03-23
EP0002895B1 (en) 1981-10-14
YU42054B (en) 1988-04-30
CY1219A (en) 1984-04-06
NO154346B (no) 1986-05-26
IE782337L (en) 1979-06-29
YU312778A (en) 1983-01-21
SU1272984A3 (ru) 1986-11-23
YU232182A (en) 1983-01-21
AU516264B2 (en) 1981-05-28
IT1110885B (it) 1986-01-06
ZW24978A1 (en) 1980-10-22
AT365581B (de) 1982-01-25
AU4204078A (en) 1979-07-05
SU1072803A3 (ru) 1984-02-07
SU1087075A3 (ru) 1984-04-15
YU232082A (en) 1983-01-21
IE47592B1 (en) 1984-05-02
FI64357B (fi) 1983-07-29
CA1107732A (en) 1981-08-25
JPH0262532B2 (hu) 1990-12-26
DK151253C (da) 1988-05-16
PT68956A (en) 1979-01-01
DE2861170D1 (en) 1981-12-24
FI64357C (fi) 1983-11-10
JPS63119469A (ja) 1988-05-24
YU41607B (en) 1987-12-31
DK151253B (da) 1987-11-16
JPS5495582A (en) 1979-07-28
PL118443B1 (en) 1981-10-31
PH15435A (en) 1983-01-18
NO784397L (no) 1979-07-02
CS241015B2 (en) 1986-03-13
HU182585B (en) 1984-02-28
US4393062A (en) 1983-07-12
NO154346C (no) 1986-09-03
DK541878A (da) 1979-06-30
SG68683G (en) 1984-08-03
EP0002895A1 (en) 1979-07-11
IL56099A0 (en) 1979-01-31
NZ189034A (en) 1981-11-19
DD141021A5 (de) 1980-04-09
YU42807B (en) 1988-12-31
FI783844A7 (fi) 1979-06-30
JPS6326110B2 (hu) 1988-05-27
US4251528A (en) 1981-02-17

Similar Documents

Publication Publication Date Title
BG34336A3 (bg) Метод за получаване на производни на фталазин -4- ил-оцетна киселина
BG31225A3 (bg) Метод за получаване на ациланилидни производни
BG30015A3 (bg) Метод за получаване на трифенилалкенови производни
BG30474A3 (bg) Метод за получаване на 6-п-пропил-8-метоксиметил-или- метилмеркаптометилерголини и сродни съединения
BG35189A3 (en) Method for preparing derivatives of 6- beta- hydroxyalkylpenicillanic acid
BG34614A3 (bg) Метод за получаване на производни на пеницилановата киселина
BG31945A3 (bg) Метод за получаване на 4-ациламино-фенил-етаноламини
BG34338A3 (bg) Метод за получаване на тиадиазолилцефалоспорини
BG32850A3 (bg) Метод за получаване на 6а,10а-цис-хексахидро- -дибензопиранони
BG32854A3 (bg) Метод за получаване на 1- оксадетиацефалоспорини
BG28049A3 (bg) Метод за получаване на 2-бром-6-флуор-n-2-имидазолиди-нилиден- бензамин и неговите присъединителни с киселина соли
BG30927A3 (bg) Метод за получаване на транс-4-алфа-фенил-октахидро-1н-2 пиридини
BG30175A4 (en) Method of obtaining of pyridon compounds
BG28565A3 (bg) Метод за получаване на пиролхиноксалинони и пиролбензодиазепинони
BG32116A3 (bg) Метод за получаване на 4''-амино-олеандомицинови производни
BG28415A4 (bg) Метод за получаване на 9-хидроксиоктахидробензо(с) хинолини
BG31947A3 (bg) Метод за получаване на ацетидинови производни
BG35032A3 (bg) Метод за получаване на 1, 1, 2- трифенилпропенови производни
BG30017A3 (en) Method for obtaining of bensoilcarbrmid
BG28066A3 (bg) Метод за получаване на пиридобензодиазепинони
BG29284A3 (bg) Метод за получаване на 3-ди-п пропилацетокси бензодиазепин-2-они
BG34456A3 (bg) Метод за получаване на производни на 7 бета- аминотиазолилацетамидо- 3- цефем- 4- карбоновата киселина
BG30926A3 (bg) Метод за получаване на n-(1-метил-2-пиролидинилметил-2,3-диметокси- 5-метилсулфамоилбензамид и негови производни
BG28570A3 (bg) Метод за получаване на 1-фенил-2-амино-1,3-пропандиол-n алкилови производни
BG29283A3 (en) Method of obtaining of imidazole derivatives